Observed reduction in false measles IgM positivity using an ELISA kit containing RF absorbent

Berksan Simsek1, Buket Toksoy Cakici2

  • 1Department of Medical Microbiology Laboratory, Istanbul Provincial Health Directorate Taksim Training and Research Hospital, Istanbul, Türkiye.

PubMed

Insights

A Rheumatoid Factor (RF) absorbent ELISA assay significantly improved measles IgM test specificity. This diagnostic tool reduced false positives by 91%, enhancing accuracy for measles surveillance in low-prevalence areas.

Area of Science:

  • Immunology
  • Infectious Disease Diagnostics
  • Epidemiology

Background:

  • Measles IgM ELISA assays can yield false-positive results, particularly in low-prevalence settings.
  • High false-positive rates compromise the accuracy of measles surveillance and outbreak investigations.

Purpose of the Study:

  • To evaluate the efficacy of a Rheumatoid Factor (RF)-absorbent ELISA assay in reducing false-positive measles IgM results.
  • To assess the impact of RF-blocking on diagnostic specificity in measles surveillance.

Main Methods:

  • Retesting of initially reactive measles IgM samples using an RF-absorbent ELISA assay.
  • Quantification of the reduction in positive or borderline results after RF absorption.

Main Results:

  • Out of 76 initially reactive samples, only 7 remained positive or borderline after RF absorption.
  • A 91% reduction in false-positive measles IgM results was observed.

Conclusions:

  • RF-absorbent ELISA assays are effective in improving the specificity of measles IgM testing.
  • Implementing RF-blocking diagnostics enhances the accuracy of measles surveillance, especially in low-prevalence populations.